Jeffrey Sherman Net Worth & Insider Trades
Jeffrey Sherman - EVP and Chief Medical Officer, Horizon Therapeutics Public Ltd Co
What is Jeffrey Sherman's Net Worth?
The current estimated net worth of Horizon Therapeutics Public Ltd Co's EVP and Chief Medical Officer, Jeffrey Sherman, is estimated to be about $27.97M . Jeffrey Sherman owns about 116,437 units of Horizon Therapeutics Public Ltd Co common stock. In the last 11 years at Horizon Therapeutics Public Ltd Co, Jeffrey Sherman has sold an estimated value of $31.82M worth.
What is Jeffrey Sherman's Past Insider Trading?
Jeffrey Sherman's largest purchase order was 50,313 units , worth over $352.12K on September 23, 2021. Jeffrey Sherman's largest sale order was 103,842 units , worth over $7.38M on December 9, 2020. In total, Jeffrey Sherman has made about 45 transactions over 11 years of their time at Horizon Therapeutics Public Ltd Co. Jeffrey Sherman usually trades in January, with the busiest year in 2015. The most recent transaction was a sale order of 42,009 units , worth over $4.62M on April 8, 2022.
JEFFREY SHERMAN
Ticker
|
Type
|
Value
|
Price per Share
|
Shares
|
Filing Date
| ||
|---|---|---|---|---|---|---|---|
| No matching records found | |||||||
What was Jeffrey Sherman's Salary in 2020?
As EVP and Chief Medical Officer of Horizon Therapeutics Public Ltd Co, Jeffrey Sherman has a total base salary of $578,731 . Jeffrey Sherman received compensation valued at about $5,261,300 in 2020 after becoming EVP and Chief Medical Officer. The vast majority of their compensation came in the form of other earnings, plans or compensations of $92,545 , other earnings, plans or compensations of $92,545 , other earnings, plans or compensations of $92,545 , and other earnings, plans or compensations of $92,545 .
What is Jeffrey Sherman's' Mailing Address?
- Mailing address is C/o Idm Pharma, Inc. 9 Parker, Suite 100 Irvine CA 92618 CA
Horizon Therapeutics Public Ltd Co Executive Compensation
Name |
Year
|
Salary
|
Bonus
|
Other Earnings Plans or Compensations
|
Other Earnings Plans or Compensations
|
Other Earnings Plans or Compensations
|
Other Earnings Plans or Compensations
|
Total
|
|---|---|---|---|---|---|---|---|---|
| Timothy P. Walbert | 2020 | $1,146,542 | - | $199,548 | $199,548 | $199,548 | $199,548 | $21,632,803 |
| Timothy P. Walbert | 2019 | $1,108,700 | - | $226,871 | $226,871 | $226,871 | $226,871 | $13,873,172 |
| Timothy P. Walbert | 2018 | $1,076,250 | - | $160,363 | $160,363 | $160,363 | $160,363 | $16,796,894 |
| Paul W. Hoelscher | 2020 | $600,569 | - | $106,485 | $106,485 | $106,485 | $106,485 | $5,915,146 |
| Paul W. Hoelscher | 2019 | $580,748 | - | $120,135 | $120,135 | $120,135 | $120,135 | $4,443,588 |
| Paul W. Hoelscher | 2018 | $563,750 | - | $104,332 | $104,332 | $104,332 | $104,332 | $7,034,386 |
| Andy Pasternak | 2020 | $669,021 | $250,000 | $66,872 | $66,872 | $66,872 | $66,872 | $5,826,126 |
| Andy Pasternak | 2019 | $108,333 | $500,000 | $19,188 | $19,188 | $19,188 | $19,188 | $2,924,542 |
| Jeffrey W. Sherman, M.D., FACP | 2020 | $578,731 | - | $92,545 | $92,545 | $92,545 | $92,545 | $5,261,300 |
| Jeffrey W. Sherman, M.D., FACP | 2019 | $559,630 | - | $95,222 | $95,222 | $95,222 | $95,222 | $3,568,496 |
| Jeffrey W. Sherman, M.D., FACP | 2018 | $543,250 | - | $68,263 | $68,263 | $68,263 | $68,263 | $3,678,874 |
| Barry J. Moze | 2020 | $628,960 | - | $75,659 | $75,659 | $75,659 | $75,659 | $5,073,877 |
| Barry J. Moze | 2019 | $608,201 | - | $58,744 | $58,744 | $58,744 | $58,744 | $4,662,510 |
| Barry J. Moze | 2018 | $590,400 | - | $35,114 | $35,114 | $35,114 | $35,114 | $2,732,565 |
| No matching records found | ||||||||
Source: https://www.sec.gov/Archives/edgar/data/1492426/000119312521084225/d42343ddef14a.htm
What are Horizon Therapeutics Public Ltd Co's Past Insider Trades?
Horizon Therapeutics Public Ltd Co's most recent insider trade came on August 8, 2022 by Sean Clayton who bought 745 units worth $49.67K . In the last 11 years, insiders at Horizon Therapeutics Public Ltd Co have sold an estimated value of $682.77M and bought an estimated value of $119.53M worth of shares. Insider trading is most common in May and January, with the busiest year in 2021. The most active traders at the company are Timothy Walbert, Chairman, Jeffrey Sherman, EVP and Chief Medical Officer, and Paul Hoelscher, EVP .
Horizon Therapeutics Public Ltd Co Insider Trades
Insider Names
|
Type
|
Value
|
Price per Share
|
Shares
|
Filing Date
| ||
|---|---|---|---|---|---|---|---|
| No matching records found | |||||||